Why Vivani Medical, Inc.’s (VANI) Stock Is Down 5.03%
As of Friday, July 24, Vivani Medical, Inc.’s VANI share price has dipped by 5.03%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: Vivani Medical, Inc. (VANI)
Vivani Medical, Inc. VANI
$1.38
-0.03
-2.13%
August 21, 2026 4:00:00 PM
EST
Volume: 104,718
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Commentary & Analysis
Why Vivani Medical, Inc.’s (VANI) Stock Is Up 5.56%
As of Tuesday, July 21, Vivani Medical, Inc.’s VANI share price has surged by 5.56%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Vivani Medical, Inc.’s (VANI) Stock Is Down 5.77%
As of Friday, July 10, Vivani Medical, Inc.’s VANI share price has dipped by 5.77%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Vivani Medical, Inc.’s (VANI) Stock Is Down 13.78%
As of Friday, July 10, Vivani Medical, Inc.’s VANI share price has dipped by 13.78%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Vivani Medical, Inc.’s (VANI) Stock Is Up 12.55%
As of Wednesday, July 08, Vivani Medical, Inc.’s VANI share price has surged by 12.55%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | VANI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $124.5 | $422.9 | 23% |
|
| Shares Out (Mil) | 87.1 | 41.4 | 59% |
|
| Institutional Ownership | 12.4% | 83.6% | 7% |
|
| Float (Mil) | 34.9 | 34.9 | 39% |
|
| Beta | 3.28 | 0.88 | 98% |
|
| Avg Daily Volume (000s) | 219 | 409 | 45% |
|
| Price Change (52-week) |
13.1% | 66.3% | 56% |
|
| Growth | VANI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.9% | na |
|
| Net Income (5yr) | (23.4%) | (5.9%) | 18% |
|
| EPS (5yr) | 14.6% | 10.4% | 55 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (17.2%) | (16.2%) | 41% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | VANI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $123 | na |
|
| Net Income (TTM) (Mil) | ($26) | ($9) | 22% |
|
| EPS (TTM) | ($0.351) | ($0.400) | 30% |
|
| Operating Cash Flow (TTM) (Mil) | ($25) | ($3) | 13% |
|
| Net Cash Flow (TTM) (Mil) | $13 | $1 | 58% |
|
| Long-Term Debt (Q1) (Mil) | $16 | $22 | 31% |
|
| Enterprise Value (Q1) (Mil) | $125 | $418 | 23% |
|
| Valuation | VANI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.57 | 3.13 | 83% |
|
| P/E | na | 28.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | VANI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 58.7% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (74.6%) | (12.3%) | 8% |
|
| ROE | (220.4%) | (12.3%) | 4% |
|
| Liabilities to Assets | 54.4% | 46.0% | 47% |
|
| F-Score | 2 | 4 | 7% |
|
Vivani Medical, Inc. did not pass any screens on 8/21/2026.
